Serum 25-hydroxyvitamin D and breast cancer in the military: a case–control study utilizing pre-diagnostic serum
- 481 Downloads
The objective of this study was to ascertain whether a relationship exists between pre-diagnostic serum levels of 25-hydroxyvitamin D (25(OH)D) and risk of breast cancer in young women.
About 600 incident cases of breast cancer were matched to 600 controls as part of a nested case–control study that utilized pre-diagnostic sera. Logistic regression was used to assess the relationship between serum 25(OH)D concentration and breast cancer risk, controlling for race and age.
According to the conditional logistic regression for all subjects, odds ratios for breast cancer by quintile of serum 25(OH)D from lowest to highest were 1.2, 1.0, 0.9, 1.1, and 1.0 (reference) (p trend = 0.72). After multivariate regression for subjects whose blood had been collected within 90 days preceding diagnosis, odds ratios for breast cancer by quintile of serum 25(OH)D from lowest to highest were 3.3, 1.9, 1.7, 2.6, and 1.0 (reference) (p trend = 0.09).
An inverse association between serum 25(OH)D concentration and risk of breast cancer was not present in the principal analysis, although an inverse association was present in a small subgroup analysis of subjects whose blood had been collected within 90 days preceding diagnosis. Further prospective studies of 25(OH)D and breast cancer risk are needed.
KeywordsVitamin D Breast neoplasms Case–control studies 25-hyrdoxyvitamin D Epidemiology
This research was supported by a Congressional allocation to the Penn State Cancer Institute of the Hershey Medical Center, Hershey, PA, through the Department of the Navy, Bureau of Medicine and Surgery, under Work Unit No. 60126 at the Naval Health Research Center (San Diego, CA, USA). The views presented here are solely the opinions of the authors and do not represent an official position of the Department of the Navy, the Department of Defense, or the U.S. Government. Approved for public release; distribution unlimited. Thanks to Dr. Angelee Ferber of the U.S. Army Medical Research and Development Command for providing the blood samples used in this study and for her outstanding support of the research. Thanks to June J. Kim, B.S., of Naval Health Research Center for her valued work editing the manuscript.
- 2.Gorham E, Garland C, Garland F (1989) Acid haze air pollution and breast and colon cancer in 20 Canadian cities. Can J Publ Health 80:96–100Google Scholar
- 7.Grant WB (2012) Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers. J Photochem Photobiol B 101(2):130–136, 3 NovGoogle Scholar
- 9.Garland C, al. e. (1990) Levels of serum 25-hydroxyvitamin D, 60 individuals aged 60+ years [Graph]. Rancho Bernardo, CAGoogle Scholar
- 14.John E, Schwartz G, Dreon D, Koo J (1999) Vitamin D and breast cancer risk: the NHANES I epidemiologic follow-up study, 1971–1975 to 1992. Cancer Epidemiol Biomark Prev 8:399–406Google Scholar
- 30.Garland C, Gorham E, Garland F (2009) Vitamin D for cancer prevention: global perspective. Ann Epidemiol 19(7):468–483Google Scholar
- 33.Almquist M, Bondeson AG, Bondeson L, Malm J, Manjer J (2010) Serum levels of vitamin D, PTH and calcium and breast cancer risk-a prospective nested case-control study. Int J Cancer Journal international du cancer 127(9):2159–2168, 1 NovGoogle Scholar
- 34.Eliassen AH, Spiegelman D, Hollis BW, Horst RL, Willett WC, Hankinson SE (2011) Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses’ Health Study II. Breast Cancer Res BCR 13(3):R50Google Scholar
- 35.Mohr SB, Gorham ED, Alcaraz JE, Kane CJ, Macera CA, Parsons JK, et al (2011) Serum 25-hydroxyvitamin D and prevention of breast cancer: pooled analysis. Anticancer Res 31(9):2939–2948, SepGoogle Scholar
- 36.Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H (2012) Meta-analysis: serum vitamin D and breast cancer risk. Eur J Cancer 46(12):2196–2205, AugGoogle Scholar
- 37.Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ, et al (2012) Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 128(6):1414–1424, 15 MarGoogle Scholar
- 38.Chen P, Hu P, Xie D, Qin Y, Wang F, Wang H (2010) Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treatment 121(2):469–477, JunGoogle Scholar
- 43.Mantel N (1963) Chi square tests with one degree of freedom; extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 58:690–700Google Scholar
- 44.Bluff JE, Brown NJ, Reed MW, Staton CA (2008) Tissue factor, angiogenesis and tumour progression. Breast Cancer Res BCR 10(2):204Google Scholar
- 46.Merck Manual of Diagnosis and Therapy (2003) Breast disorders: cancer. In: Robert S, Porter M (ed). Merck Publishing Group, Whitehouse StationGoogle Scholar
- 47.van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, et al (2000) Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 152(6):514–527, 15 SepGoogle Scholar
- 49.Gesink Law DC, Maclehose RF, Longnecker MP (2007) Obesity and time to pregnancy. Hum Reprod 22(2):414–420, FebGoogle Scholar
- 57.Friedenreich CM (2012) Physical activity and breast cancer: review of the epidemiologic evidence and biologic mechanisms. Recent Results Cancer Res 188:125–139Google Scholar
- 58.Anderson LN, Cotterchio M, Kirsh VA, Knight JA (2011) Ultraviolet sunlight exposure during adolescence and adulthood and breast cancer risk: a population-based case-control study among Ontario women. Am J Epidemiol 174(3):293–304, 9 JunGoogle Scholar